Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU’s IMI, Drug Makers And Universities Join In New R&D Effort

This article was originally published in The Pink Sheet Daily

Executive Summary

Europe’s latest push to speed up new medicine discovery will see a new European Lead Factory set up under the EU’s Innovative Medicines Initiative, combining a library of up to 500,000 drug candidates from industry and academia and high-throughput screening centers to identify and generate new therapies.

Advertisement

Related Content

Can Merck Serono Bounce Back?
Emerging Markets, U.S. Provide Better Incubation Environment For Biotech Than Europe, Says Sanofi’s Viehbacher
U.S. Provides Better Incubation Environment For Biotech Than Europe, Says Sanofi’s Viehbacher
Europe To Drive Global R&D Collaborations With Pharma Companies
Public-Private Partnerships Like IMI Crucial to Industry's Future, Argue Leaders

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS075359

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel